133 related articles for article (PubMed ID: 8768828)
21. Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men.
Gentili A; Mulligan T; Godschalk M; Clore J; Patrie J; Iranmanesh A; Veldhuis JD
J Clin Endocrinol Metab; 2002 Feb; 87(2):825-34. PubMed ID: 11836328
[TBL] [Abstract][Full Text] [Related]
22. Growth hormone (GH) and insulin-like growth factor I responses after treatments with an orally active GH secretagogue L-163,255 in swine.
Chang CH; Rickes EL; McGuire L; Frazier E; Chen H; Barakat K; Nargund R; Patchett A; Smith RG; Hickey GJ
Endocrinology; 1996 Nov; 137(11):4851-6. PubMed ID: 8895356
[TBL] [Abstract][Full Text] [Related]
23. Effect of the Orally Active Growth Hormone Secretagogue MK-677 on Somatic Growth in Rats.
Lee J; Kwon A; Chae HW; Lee WJ; Kim TH; Kim HS
Yonsei Med J; 2018 Dec; 59(10):1174-1180. PubMed ID: 30450851
[TBL] [Abstract][Full Text] [Related]
24. A quantitative estimation of growth hormone secretion in normal man: reproducibility and relation to sleep and time of day.
Van Cauter E; Kerkhofs M; Caufriez A; Van Onderbergen A; Thorner MO; Copinschi G
J Clin Endocrinol Metab; 1992 Jun; 74(6):1441-50. PubMed ID: 1592892
[TBL] [Abstract][Full Text] [Related]
25. Continuous subcutaneous infusions of growth hormone (GH) releasing hormone 1-44 for 14 days increase GH and insulin-like growth factor-I levels in old men.
Corpas E; Harman SM; Piñeyro MA; Roberson R; Blackman MR
J Clin Endocrinol Metab; 1993 Jan; 76(1):134-8. PubMed ID: 8421077
[TBL] [Abstract][Full Text] [Related]
26. Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in man.
Copinschi G; Leproult R; Van Onderbergen A; Caufriez A; Cole KY; Schilling LM; Mendel CM; De Lepeleire I; Bolognese JA; Van Cauter E
Neuroendocrinology; 1997 Oct; 66(4):278-86. PubMed ID: 9349662
[TBL] [Abstract][Full Text] [Related]
27. Regulation of the growth hormone-insulin-like growth factor I axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor I.
Wilson ME
J Clin Endocrinol Metab; 1998 Jun; 83(6):2018-28. PubMed ID: 9626134
[TBL] [Abstract][Full Text] [Related]
28. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
Morales AJ; Nolan JJ; Nelson JC; Yen SS
J Clin Endocrinol Metab; 1994 Jun; 78(6):1360-7. PubMed ID: 7515387
[TBL] [Abstract][Full Text] [Related]
29. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
[TBL] [Abstract][Full Text] [Related]
30. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea.
Laughlin GA; Dominguez CE; Yen SS
J Clin Endocrinol Metab; 1998 Jan; 83(1):25-32. PubMed ID: 9435412
[TBL] [Abstract][Full Text] [Related]
31. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
Murphy MG; Weiss S; McClung M; Schnitzer T; Cerchio K; Connor J; Krupa D; Gertz BJ;
J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495
[TBL] [Abstract][Full Text] [Related]
32. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
[TBL] [Abstract][Full Text] [Related]
33. Twenty-four-hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation.
Hokken-Koelega AC; Hackeng WH; Stijnen T; Wit JM; de Muinck Keizer-Schrama SM; Drop SL
J Clin Endocrinol Metab; 1990 Sep; 71(3):688-95. PubMed ID: 2394775
[TBL] [Abstract][Full Text] [Related]
34. Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects.
Hilding A; Brismar K; Degerblad M; Thorén M; Hall K
J Clin Endocrinol Metab; 1995 Sep; 80(9):2646-52. PubMed ID: 7545695
[TBL] [Abstract][Full Text] [Related]
35. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
[TBL] [Abstract][Full Text] [Related]
36. Assessment of growth hormone (GH) secretion in men with adult-onset GH deficiency compared with that in normal men--a clinical research center study.
Baum HB; Biller BM; Katznelson L; Oppenheim DS; Clemmons DR; Cannistraro KB; Schoenfeld DA; Best SA; Klibanski A
J Clin Endocrinol Metab; 1996 Jan; 81(1):84-92. PubMed ID: 8550799
[TBL] [Abstract][Full Text] [Related]
37. Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers.
de Boer H; Blok GJ; Popp-Snijders C; Stuurman L; Baxter RC; van der Veen E
J Clin Endocrinol Metab; 1996 Apr; 81(4):1371-7. PubMed ID: 8636336
[TBL] [Abstract][Full Text] [Related]
38. Dehydroepiandrosterone supplementation in women with adrenal failure: impact on twenty-four hour GH secretion and IGF-related parameters.
Christiansen JJ; Gravholt CH; Fisker S; Svenstrup B; Bennett P; Veldhuis J; Andersen M; Christiansen JS; Jørgensen JO
Clin Endocrinol (Oxf); 2004 Apr; 60(4):461-9. PubMed ID: 15049961
[TBL] [Abstract][Full Text] [Related]
39. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects.
Rasmussen MH; Hvidberg A; Juul A; Main KM; Gotfredsen A; Skakkebaek NE; Hilsted J; Skakkebae NE
J Clin Endocrinol Metab; 1995 Apr; 80(4):1407-15. PubMed ID: 7536210
[TBL] [Abstract][Full Text] [Related]
40. Morning versus evening administration of estradiol to girls with turner syndrome receiving growth hormone: impact on growth hormone and metabolism. A randomized placebo-controlled crossover study.
Naeraa RW; Gravholt CH; Kastrup KW; Svenstrup B; Christiansen JS
Acta Paediatr; 2001 May; 90(5):526-31. PubMed ID: 11430712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
